ARDELYX, INC. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
ARDELYX, INC. (ARDX) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $3.02 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2026-08-06
- 2026-06-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $3.02M.
- 2026-03-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $1.03M.
- 2025-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $1.13M.
- 2025-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $1.23M.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2026-06-30 | $3.02M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.03M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $1.13M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.23M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $1.32M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $1.07M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $1.14M 10-K · filed 2026-02-19 |
| 2024-09-30 | $944.00K 10-Q · filed 2024-10-31 |
| 2024-06-30 | $1.05M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $1.11M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $912.00K 10-K · filed 2025-02-20 |
| 2023-09-30 | $1.28M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $1.28M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $1.28M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $1.11M 10-K · filed 2023-03-02 |
| 2022-09-30 | $1.19M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.26M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.40M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $235.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $307.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $378.00K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $449.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $518.00K 10-K · filed 2021-03-08 |
| 2020-09-30 | $467.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $561.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $652.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $741.00K 10-K · filed 2020-03-06 |
| 2019-09-30 | $827.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $911.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $991.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $1.09M 10-K · filed 2019-03-06 |
| 2018-09-30 | $1.14M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $1.22M 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |